Under infrared illumination, these SuperDots selectively produce bright blue, red and infrared light, with a staggering thousand times more sensitivity than existing materials. "Neither the glass of the optical fibre nor other background biological molecules respond to infrared, so that removed the background signal issue. By exciting these SuperDots we were able to lower the detection limit to the ultimate level a single nanoparticle," says Jin.
"The trans-disciplinary research from multiple institutions has paved the way for this innovative discovery," says Jin, "with the interface of experts in nanomaterials, photonics engineering, and biomolecular frontiers."
"These joint efforts will ultimately benefit patients around the world - for example, our industry partners Minomic International Ltd and Patrys Ltd are developing uses for SuperDots in cancer diagnostic kits, detecting incredibly low numbers of biomarkers within conditions like prostate and multiple myeloma cancer." Macquarie is now actively seeking other industrial partners with the capacity to jointly develop solutions outside of these fields.
|Contact: Tanya Monro|
University of Adelaide